Kano Therapeutics
Floris Engelhardt has extensive experience in research and entrepreneurship, holding positions at various prestigious institutions such as Kano Therapeutics, University of Massachusetts Boston, Activate, Massachusetts Institute of Technology, and Technische Universität München. With a background in biochemistry and molecular biology, Floris has pursued higher education at Technical University of Munich, University of York, and Friedrich Schiller University Jena. More information can be found at http://bathebionano.org.
This person is not in any teams
Kano Therapeutics
Kano Therapeutics is a founder-led biotech startup enabling safe, effective, and flexible correction of gene-length stretches of DNA through a new class of biomaterials. By building a “one stop shop” product development platform for single-stranded DNA templates that combines manufacturing, application, and computational tools we bridge the gap between editing genes and totally replacing them, empowering scientists, labs, and companies with the building blocks they need to cross the chasm to cures.